Sandoz’s Filgrastim Biosimilar Relies On Data Extrapolation, “The Pink Sheet” July 24, 2014
Biosimilars’ Next Hurdle In EU Is Physician Opposition To Extrapolation, “The Pink Sheet” August 4, 2014
Biosimilars: Like a Deer in the Headlines
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
